These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeting IgE to facilitate oral immunotherapy for food allergy: a potential new role for anti-IgE therapy? Umetsu DT Expert Rev Clin Immunol; 2014 Sep; 10(9):1125-8. PubMed ID: 25119422 [TBL] [Abstract][Full Text] [Related]
4. Forecast for food allergen immunotherapy: partly desensitized or a chance of cure? Narisety SD; Wood RA Expert Rev Clin Immunol; 2010 Mar; 6(2):177-9. PubMed ID: 20402377 [No Abstract] [Full Text] [Related]
5. Safety of Food Oral Immunotherapy: What We Know, and What We Need to Learn. Vázquez-Cortés S; Jaqueti P; Arasi S; Machinena A; Alvaro-Lozano M; Fernández-Rivas M Immunol Allergy Clin North Am; 2020 Feb; 40(1):111-133. PubMed ID: 31761113 [TBL] [Abstract][Full Text] [Related]
7. The Use of Omalizumab in Food Oral Immunotherapy. Labrosse R; Graham F; Des Roches A; Bégin P Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):189-199. PubMed ID: 27628022 [TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trials investigating the role of allergen exposure in food allergy: where are we now? Metcalfe J; Prescott SL; Palmer DJ Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):296-305. PubMed ID: 23549151 [TBL] [Abstract][Full Text] [Related]
9. Epicutaneous immunotherapy: the next step for food allergy desensitization. De Jong NW Expert Rev Clin Immunol; 2018 Dec; 14(12):977-978. PubMed ID: 30295101 [No Abstract] [Full Text] [Related]
10. Does clinical protection persist after food allergen oral immunotherapy? Vickery BP Immunotherapy; 2015; 7(8):851-3. PubMed ID: 26314347 [No Abstract] [Full Text] [Related]
11. Comparisons of outcomes with food immunotherapy strategies: efficacy, dosing, adverse effects, and tolerance. Yanagida N; Sato S; Asaumi T; Ebisawa M Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):396-403. PubMed ID: 27362325 [TBL] [Abstract][Full Text] [Related]
12. Food allergy therapy: is a cure within reach? Nowak-Węgrzyn A; Muraro A Pediatr Clin North Am; 2011 Apr; 58(2):511-30, xii. PubMed ID: 21453816 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions. Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175 [No Abstract] [Full Text] [Related]
16. Anaphylaxis caused by allergen sublingual immunotherapy? André C; Fadel R Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597 [No Abstract] [Full Text] [Related]
17. Food allergy in childhood: Are we close to having an effective treatment? Alvaro M; Escarrer M Allergol Immunopathol (Madr); 2017; 45(4):313-315. PubMed ID: 28688477 [No Abstract] [Full Text] [Related]
18. Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis. Benken ST; Nyenhuis SM; Dunne S J Allergy Clin Immunol Pract; 2017; 5(1):195-197. PubMed ID: 27838324 [No Abstract] [Full Text] [Related]
19. Recent advances in immunotherapy: the active treatment of food allergy on the horizon. Pajno GB; Caminiti L; Crisafulli G; Salzano G Expert Rev Clin Immunol; 2013 Oct; 9(10):891-3. PubMed ID: 24128153 [No Abstract] [Full Text] [Related]
20. Food allergy-From food avoidance to active treatment. Costa C; Coimbra A; Vítor A; Aguiar R; Ferreira AL; Todo-Bom A Scand J Immunol; 2020 Jan; 91(1):e12824. PubMed ID: 31486118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]